The US Food and Drug Administration has logged three drugrecalls, all inititated by the manufacturers, since March 11. Thethree recalls are:
On March 15, McKesson Packaging Services (Concord, NC), startedsending out letters recalling 4755 boxes of institutional-useSky brand blister packs and punch cards of acetaminophen (manufacturedby Magno-Humphries Laboratories of Tigard, OR) that might contain metalparticles.
On March 11, Malinckrodt (Berkeley, MO) began its recall of1194 thousand-tablet bottles of propoxyphene napsylate andacetaminophen tablets because the bottle label referred to pinktablets, while those batches of the product were white.
On April 4, Wyeth's Richmond Division (Richmond, VA) becanrecalling 28,727 thousand-tablet bottles of Premarin conjugatedestrogen tablets (in 0.625 and 0.3 mg dosages), citing dissolution failures.
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
FDA final guidance defines when companion app output counts as drug labeling and when device-connected or standalone apps belong in prescribing information.
Boyang Wang of Immortal Dragons explains how FDA's Expedited IND Pilot and QRIs could compress sequential first-in-human steps as China's Decree 818 raises the pace.